Advertisement
Advertisement
;
Advertisement

Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents

Brian I. Rini, MD, and Thomas Powles, MD, PhD, on Renal Cell Carcinoma: Results From the KEYNOTE-426 Trial on Pembrolizumab Plus Axitinib vs Sunitinib

Zaida Morante, MD, on Triple-Negative Breast Cancer: Delaying Adjuvant Chemotherapy

John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome

Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies